Hedge Fund - Algert Coldiron Investors
Supernus Pharmaceuticals Inc. (SUPN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $473,000 | 0.01% | 9,510 | $48.62 |
| 2 | 2025 - Q3 (2025-09-30) | $1,354,000 | 0.02% | 28,330 | $40.27 |
| 3 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $34.75 |
| 4 | 2022 - Q3 (2022-09-30) | $437,000 | 0.02% | 12,920 | $32.54 |
| 5 | 2022 - Q2 (2022-06-30) | $249,000 | 0.01% | 8,608 | $28.64 |
| 6 | 2022 - Q1 (2022-03-31) | $219,000 | 0.01% | 6,778 | $30.66 |
| 7 | 2021 - Q4 (2021-12-31) | $0 | 0% | 0 | $30.34 |
| 8 | 2021 - Q3 (2021-09-30) | $212,000 | 0.02% | 7,955 | $26.84 |
| 9 | 2020 - Q1 (2020-03-31) | $0 | 0% | 0 | $21.01 |
| 10 | 2019 - Q4 (2019-12-31) | $453,000 | 0.13% | 19,090 | $24.29 |
| 11 | 2019 - Q3 (2019-09-30) | $1,185,000 | 0.44% | 43,123 | $29.63 |
| 12 | 2019 - Q2 (2019-06-30) | $735,000 | 0.27% | 22,210 | $34.26 |
| 13 | 2019 - Q1 (2019-03-31) | $657,000 | 0.37% | 18,758 | $37.21 |
| 14 | 2018 - Q4 (2018-12-31) | $843,000 | 0.23% | 25,363 | $43.00 |
| 15 | 2018 - Q3 (2018-09-30) | $406,000 | 0.08% | 8,061 | $49.38 |
| 16 | 2018 - Q2 (2018-06-30) | $482,000 | 0.1% | 8,061 | $51.80 |
| 17 | 2018 - Q1 (2018-03-31) | $5,092,000 | 0.98% | 111,183 | $41.73 |
| 18 | 2017 - Q4 (2017-12-31) | $2,664,000 | 0.62% | 66,863 | $39.52 |
| 19 | 2017 - Q3 (2017-09-30) | $2,507,000 | 0.57% | 62,681 | $43.28 |
| 20 | 2017 - Q2 (2017-06-30) | $2,231,000 | 0.62% | 51,767 | $35.59 |
| 21 | 2017 - Q1 (2017-03-31) | $1,835,000 | 0.49% | 58,612 | $26.80 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center